Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study
BackgroundDiabetic macular edema (DME), a leading cause of blindness, requires treatment with costly drugs, such as anti–vascular endothelial growth factor (VEGF) agents. The prolonged use of these effective but expensive drugs results in an incremental economic burden for pa...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2024-10-01
|
Series: | JMIR Public Health and Surveillance |
Online Access: | https://publichealth.jmir.org/2024/1/e56741 |